Estudio REALIST (REsiduAl risk, LIpids and Standard Therapies): Un análisis del Riesgo Residual dependiente del perfil lipídico en el síndrome coronario agudo
(2011) Endocrinologia y Nutricion — Vol. 58, n° 1, p. 38-47 (2011)
Files
No attached file found for this publication.
Details
- Authors
- Abstract
- (en) The R3i Foundation (Residual Risk Reduction Initiative), an independent, multinational and academic organization, is conducting the REALIST (Residual Risk, Lipids and Standard Therapies) study in 40 centers in different countries. This is a retrospective epidemiological study, designed to provide new data on the residual risk of major coronary events attributable to lipid abnormalities in patients receiving the current standard treatment. The initial results are expected in mid 2010, and the overall results at the end of 2010.
- Affiliations
Citations
Millán Núñez-Cortés, J., Montoya, J. P.-B., Salas, X. P., Hernández Mijares, A., Carey, V. J., Hermans, M., Sacks, F. M., & Fruchart, J.-C. (2011). Estudio REALIST (REsiduAl risk, LIpids and Standard Therapies): Un análisis del Riesgo Residual dependiente del perfil lipídico en el síndrome coronario agudo. Endocrinologia y Nutricion, 58(1), 38-47. https://doi.org/10.1016/j.endonu.2010.10.004 (Original work published 2011)